Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer, Inc. (NASDAQ:SEER) Sees Large Decrease in Short Interest
05:38am, Monday, 27'th Apr 2026
Seer, Inc. (NASDAQ: SEER - Get Free Report) was the target of a significant drop in short interest in the month of April. As of April 15th, there was short interest totaling 432,590 shares, a drop of
The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.
07:00am, Friday, 24'th Apr 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), who collectively own approximately 7.6% of the outstanding shares
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
01:55pm, Monday, 13'th Apr 2026
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today confi
Seer Shares Jump On Takeover Proposal
10:36am, Monday, 13'th Apr 2026
Seer, Inc. (NASDAQ: SEER) shares are trading higher Monday after the company announced that the Radoff-JEC Group submitted a non-binding proposal to acquire the company.
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.
08:00am, Monday, 13'th Apr 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), who collectively own approximately 7.6% of the outstanding shares
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
08:00am, Thursday, 09'th Apr 2026
REDWOOD CITY, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph® Produc
Patent Board Upholds Seer's Nano and Micro Particle Protein Enrichment Patent in a Challenge by Bruker Subsidiaries
07:00am, Monday, 30'th Mar 2026
23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer's Proteograph® Product Suite 23 claims of U.S. Patent No. 11,435,360 remain valid, supporting Seer's Proteograph® Product Suite
The Radoff-JEC Group Sends Open Letter to Seer, Inc. Unconflicted Independent Directors Meeta Gulyani and Nicolas Roelofs
08:00am, Wednesday, 04'th Mar 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), who collectively own approximately 7.6% of the outstanding common
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
10:17pm, Thursday, 26'th Feb 2026
Seer, Inc. (SEER) Q4 2025 Earnings Call Transcript
Seer Adopts Limited Duration Tax Benefit Preservation Plan to Protect its Valuable Tax Assets
04:06pm, Thursday, 26'th Feb 2026
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors un
Seer Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Outlook
04:05pm, Thursday, 26'th Feb 2026
REDWOOD CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the fourt
The Radoff-JEC Group Issues Open Letter to Seer Inc.'s Board of Directors Regarding the Immediate Need for Significant Change
08:30am, Monday, 23'rd Feb 2026
HOUSTON--(BUSINESS WIRE)--Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the “Radoff-JEC Group”), who collectively own nearly 7.5% of the outstanding common stock
Nathan Basisty, Sasha Singh, Bruce Wilcox, and Mozhgan Boroumand among scientific leaders presenting unique proteomics-enabled biological insights Nathan Basisty, Sasha Singh, Bruce Wilcox, and Mozhga
Seer to Participate in the TD Cowen 46th Annual Health Care Conference
04:05pm, Wednesday, 18'th Feb 2026
REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be parti
Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
04:05pm, Thursday, 05'th Feb 2026
REDWOOD CITY, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial
